NCD

Convatec launches new Esteem Body™ with Leak Defense™

Retrieved on: 
Monday, April 15, 2024
Consensus, International, Skin, Tension, FEA, Research, Finite element method, McNichol, Convatec, Patent, NCD, Leak, Stoma, Lancet, Nursing

BRIDGEWATER, N.J., April 15, 2024 /PRNewswire/ -- Convatec, a leading global medical products and technologies company, today announces that it has launched Esteem Body™ with Leak Defense™ in the United States. 

Key Points: 
  • BRIDGEWATER, N.J., April 15, 2024 /PRNewswire/ -- Convatec, a leading global medical products and technologies company, today announces that it has launched Esteem Body ™ with Leak Defense™ in the United States.
  • The trend has driven abdominal topography changes and related challenges for ostomy care management, such as skin folds and complicated abdominal contours.
  • Convatec's Esteem Body™ offers eight different combinations of these key characteristics, with four 'tension locations' (split centrally and peripherally) across two different 'convex depths'.
  • (January 11, 2024) Impact of Stoma Baseplate Convexity on Tension and Compression Around the Stoma Site: A Finite Element Analysis.

NCD announces new Chair Claudia L. Gordon

Retrieved on: 
Tuesday, April 9, 2024
Sprint Corporation, Connection, Chair, Congress, Culture, Associate, White, Howard University, National Council, Office, Policy, National Black Deaf Advocates, Mentorship, House, Council, Deafness, AT&T, National Association, Public engagement, NCD, T-Mobile US, Senate

WASHINGTON, April 09, 2024 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) – an independent, nonpartisan federal agency that advises the President, Congress, and other federal agencies on disability policy – announces Claudia L. Gordon, Esq., of Washington, D.C., as its new Chair.

Key Points: 
  • WASHINGTON, April 09, 2024 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) – an independent, nonpartisan federal agency that advises the President, Congress, and other federal agencies on disability policy – announces Claudia L. Gordon, Esq., of Washington, D.C., as its new Chair.
  • President Joseph R. Biden, Jr. designated Gordon as Council Chair, as announced by the White House on April 5.
  • During her time at NCD, Gordon was designated by Gallegos as Vice Chair and served on NCD’s Executive Committee.
  • “I am honored to have the opportunity to serve the country in this capacity as Chair and look forward to continuing our journey of increasing accessibility and inclusion in all walks of life,” said NCD Chair Claudia Gordon.

Congress Passes Bills Making Major Investments in Alzheimer’s

Retrieved on: 
Saturday, March 23, 2024
Congress, Medical imaging, Caregiver, Health equity, DSM-IV codes, Research, National Institute on Aging, National coverage determination, Investment, CDC, NINDS, Language, Dementia, NIA, Medicare, NCD, CMS, Pharmaceutical industry

WASHINGTON, March 23, 2024 (GLOBE NEWSWIRE) -- As part of a budget bill heading to President Biden for his signature, Congress passed major investments in the fight against Alzheimer’s; specifically demonstrating its unwavering commitment to equity and inclusion in the reporting language, which helps to foster a more equitable and just healthcare system.

Key Points: 
  • WASHINGTON, March 23, 2024 (GLOBE NEWSWIRE) -- As part of a budget bill heading to President Biden for his signature, Congress passed major investments in the fight against Alzheimer’s; specifically demonstrating its unwavering commitment to equity and inclusion in the reporting language, which helps to foster a more equitable and just healthcare system.
  • “We are thrilled to witness Congress’s steadfast 12-year commitment to Alzheimer’s research, despite ongoing budget restraints,” said UsAgainstAlzheimer’s chair and co-founder George Vradenburg.
  • UsAgainstAlzheimer’s worked to include language encouraging diversity in clinical trials, and the establishment of a brain health equity initiative to improve the integration of brain health into primary care, particularly within underrepresented communities.
  • The bill also encourages the National Institute of Biomedical Imaging and Bioengineering to collaborate with National Institute of Aging (NIA) and The National Institute of Neurological Disorders and Stroke (NINDS) to develop new technologies that could discover the earliest biological events that lead to Alzheimer’s disease and related dementias.

Newmont Completes $20 Million Global Community Support Fund, Partnering with Communities for Greater Resilience Post-Pandemic

Retrieved on: 
Friday, April 5, 2024
COVID-19, Infectious Diseases, Professional Services, Philanthropy, Mining, Minerals, Health, Environmental, Social and Governance (ESG), Other Philanthropy, Natural Resources, Employment, Partnership, Corporation, Crown Agents, Research, Recovery, NGT, Regional hospital, ASX, Incubator, Food security, Laboratory, Organic, Infection, TSX, Personal protective equipment, NEM, Vaccination, Safety, Eeyou Istchee, Sustainability, Multimedia, Fund, The Colorado Health Foundation, Ministry, NCD, Notifiable disease, PPE, Pharmaceutical industry

The objective of this fund was to provide critical financial resources to host communities where Newmont operates, targeting funds to address immediate impacts of the global pandemic while catalyzing long-term resiliency and future community development.

Key Points: 
  • The objective of this fund was to provide critical financial resources to host communities where Newmont operates, targeting funds to address immediate impacts of the global pandemic while catalyzing long-term resiliency and future community development.
  • $500,000 donation matched by the Colorado Health Foundation resulting in a $1 million total donation to the Colorado Community Support Fund to support community health and prevention for underserved populations in the state.
  • $300,000 donated to the American Red Cross Global Disaster Preparedness Center to support research and local-level grants for emergency response community resilience.
  • Crown Agents is proud to collaborate with Newmont and the Ministry of Health to contribute to the health and resilience of Suriname."

NCD, colleagues remember Andrés Gallegos

Retrieved on: 
Monday, December 4, 2023
Disability discrimination act, Motivation, Government, Health, Congress, Heart, Health equity, National Council on Disability, FEMA, Coordination, House, NCD, Council, Attention, United States Air Force, Human services, St. Louis, Knowledge, Native Americans, Policy, Senate, Family, National Council, Labour, Federal Emergency Management Agency, Indian country, Intelligence, Tetraplegia, Grief, Rehabilitation Act of 1973, Learning, Research, Rehabilitation, Bangladesh Technical Education Board, Management

WASHINGTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) has lost its Chairman Andrés J. Gallegos, 62, of Illinois, who passed away Dec. 1.

Key Points: 
  • WASHINGTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) has lost its Chairman Andrés J. Gallegos, 62, of Illinois, who passed away Dec. 1.
  • On January 20, 2021, President Biden designated Gallegos Chairman of NCD shortly after being inaugurated President of the United States.
  • Since Gallegos was appointed to the Council in 2018, NCD released 31 reports and papers--15 while chair--making systemic recommendations to improve national disability policy.
  • Chicagoan Andrés Gallegos devoted his life to inclusion, health equity and accessibility.

Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves – Hagens Berman

Retrieved on: 
Tuesday, November 21, 2023
NCD, TCAR, Hagens Berman, SAN, News, Stroke, Person, Silk Road, Stenosis, FY, SILK

SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now .
  • On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.
  • This news drove the price of Silk Medical shares down nearly 50% on Oct. 11, 2023.
  • “We’re focused on investors’ losses and investigating whether Silk Road may have misled investors about the effect of the NCD’s decision on TCAR-related revenues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

Silk Road Medical (SILK) Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys: Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, November 13, 2023
Hagens Berman, Stroke, Person, NCD, TCAR, Stenosis, News, FY, SILK, Silk Road, Pharmaceutical industry

On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.

Key Points: 
  • On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.
  • “We’re focused on investors’ losses and investigating whether Silk Road may have misled investors about the effect of the NCD’s decision on TCAR-related revenues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Silk Road Medical and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Silk Road Medical should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

The Bahamas’ National Health Insurance Authority and eClinicalWorks Report Significant Progress with Electronic Health Records

Retrieved on: 
Thursday, December 14, 2023
Technology, Diabetes, Health Technology, Telemedicine, Virtual Medicine, Software, Practice Management, Health, Data Management, Oncology, EHR, National Health Insurance Authority, Primary care, Pan American Health Organization, Patient, Electronic health record, Death, Notifiable disease, Population health, PAHO, National health insurance, NCD, Cancer, Nursing, Pharmaceutical industry, The Bahamas

The National Health Insurance Authority (NHIA) has seen significant progress since the launch of its Electronic Health Record (EHR) system.

Key Points: 
  • The National Health Insurance Authority (NHIA) has seen significant progress since the launch of its Electronic Health Record (EHR) system.
  • The NHIA has partnered with eClinicalWorks , the largest ambulatory cloud EHR and provider of digital healthcare solutions to transform healthcare delivery, and has adopted population health tools that help to analyze population health.
  • With over 150,000 residents enrolled in the NHI Bahamas program, the EHR system aims to enhance patient care, improve operational efficiency, and drive positive health outcomes.
  • “By implementing eClinicalWorks EHR and population health tools, the NHIA is better equipped to track compliance data and improve long-term patient care.”

$420+ Mn ELISpot and FluoroSpot Assay Market - Global Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023
Science, Health, Other Science, Other Health, Research, Conditional sentence, Incidence, Biotechnology, ELISpot, Vaccine, USD, Infection, Growth, NCD, Diagnosis, ELISA, Pharmaceutical industry, Assay

The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global ELISpot and FluoroSpot Assays Market is expected to reach USD 421 million by 2028 from USD 292 million in 2023, at a CAGR of 7.6%
    This report studies the ELISpot and FluoroSpot Assays market based on product, applications, End user, and region.
  • The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total ELISpot and FluoroSpot Assays market.
  • The Assay kits accounted for the largest market share in the ELISpot and FluoroSpot Assays product' smarket, during the forecast period
    The ELISpot and FluoroSpot Assay Products market is segmented into Assay kits, Analyzers, and Ancillary Products.

DELFI Diagnostics Supports Proposed Legislation to Allow CMS to Review New Blood-Based Screening Tests for Lung Cancer

Retrieved on: 
Wednesday, December 13, 2023
Liquid biopsy, Food and Drug Administration, Social, Woman, PALO, Food, Congress.gov, DELFI, Representative, Social Security, Mortality, Agency, XVIII, House, Death, FDA, Social Security Act, Steel, USPSTF, CMS, Lung cancer, Medicare, Congress, Louisiana House of Representatives, NCD, Prevent Cancer Foundation, Legislation, Public, Mobile phone, Dietary supplement

CMS currently lacks the authority to cover additional approaches to lung cancer screening, such as blood-based ("liquid biopsy") tests, even though access to more screening options may improve lung cancer screening rates.

Key Points: 
  • CMS currently lacks the authority to cover additional approaches to lung cancer screening, such as blood-based ("liquid biopsy") tests, even though access to more screening options may improve lung cancer screening rates.
  • If passed, this bill would enable CMS to use its national coverage determination (NCD) authority and existing coverage standards to review new lung cancer screening tests as well, expediting reviews of products that would enhance the existing lung cancer screening pathway."
  • The Lung Cancer Screening and Prevention Act would amend title XVIII of the Social Security Act to provide this authority, but does not mandate that CMS either review or cover any new lung cancer screening tests in the Medicare program.
  • The proposed legislation aligns with U.S. President Biden's Cancer Moonshot initiative focused on expanding equitable access to cancer screening and prevention, and could be a catalyst both to increasing lung cancer screening and lowering lung cancer mortality rates – key objectives of Healthy People 2030 .